Ilika positions for a strategic breakout at Detroit’s battery stage

Ilika Plc

The buzz around Detroit’s October showcase has quietly shifted Ilika from solid‑state innovator to strategic frontrunner in EV battery deployment.

As autumn approaches, a subtle but significant shift is playing out in the electric vehicle supply chain. Ilika, best‑known for its Goliath and Stereax solid‑state platforms, is preparing to step onto North America’s largest battery stage with more than just a booth. Behind the scenes, its executives are moving from lab‑driven breakthroughs to positioning in giga‑scale manufacturing, a pivot that hints at a transformative ambition for investors tracking long‑term scale.

Since early 2025, Ilika has marched through a sequence of milestones under the radar of mainstream media. The company’s partnership with the UK Battery Industrialisation Centre delivered its first 10 Ah prototype pouch cells via industrial‑scale roll‑to‑roll coating equipment, a process now proven to not only replicate but improve on pilot‑line yields. This technical pivot is significant because it demonstrates compatibility with factory‑scale machinery, a critical hurdle between lab success and commercial viability.

Dropping quietly in February, the announcement of “superior performance under rapid‑charge protocols” from cells produced via this scaled process sparked the confidence of both OEMs and Tier‑1 suppliers. With a growing emphasis on fast charging and driving range, such capability now sits at the core of the competitive battery agenda for EV manufacturers.

These developments are slated to surface formally at The Battery Show North America, scheduled for 6–9 October in Detroit. Ilika’s presentation, “Safer Solid State Battery Cells Yield Lighter, Cheaper and more Sustainable Electric Vehicles,” will be delivered by Denis Pasero. Positioned strategically in the conference programme, this talk signals Ilika’s shift from R&D to commercial outreach, aiming to embed credibility with industry specifiers, integrators and decision‑makers.

While other solid‑state contenders scramble for attention with flashy prototypes or headline‑grabbing partnerships, Ilika has taken a more understated route—methodically de‑risking its process, validating scale‑up, and refining its messaging for a cross‑continent audience. This is a deliberate play; instead of shouting breakthroughs, they are lining up supply‑chain integration. The importance of that shift cannot be overstated for an investor: it’s a durable pivot from IP‑rich early stage to production‑ready enterprise.

There’s also a geographic dimension to consider. Detroit, and more broadly, North America, is undergoing a rapid electrification push, underpinned by federal incentives and giga‑factory investment. For Ilika, the event offers more than exposure; it provides a bridge into networks and purchasing funnels directly connected to order flow. If their sessions resonate, they could accelerate pilot agreements or development contracts with major auto OEMs or integrators operating in the US.

On home soil, momentum continues to build in parallel. Ilika’s Goliath programme remains anchored by a £2.7 million grant and facilities investment from Project SiSTEM and UKBIC. The incoming Mpac packaging line, due online in the second half of 2025, will further strengthen its manufacturing backbone. This domestic confidence underpins the story of transatlantic ambition, an emerging narrative shaped by home‑grown scale and foreign outreach.

For investors, the sequence illustrates a common theme in capital allocation: timing matters. Many firms tout “gigafactory‑ready tech,” but Ilika’s recent announcements suggest it’s not only tech‑ready, but factory‑verified and export‑positioned. The real test ahead lies in execution, securing purchase orders, completing first‑run contracts and converting technical promises into revenue streams. The October showcase is more than a conference slot; it may be the flashpoint where pipeline meets profit.

By layering technical progress with a clear route to commercialisation and geographic engagement, Ilika is scripting a transition no investor wants to miss, especially in a sector where the gap between concept and production is often measured in years and hundreds of millions in capital.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search